New Delhi-based Salve Pharmaceuticals, a part of the Salve Group of Companies, has recently unveiled its plans to establish a new manufacturing facility at the Reliance Modern Economic Township (Reliance MET) in Jhajjar, Haryana. The commencement of operations at the new plant is expected in the first quarter of 2024.

The introduction of this plant by Salve Group aims to capitalise on various opportunities in quality control, cost efficiency, flexibility, and innovation for their products.

By establishing this facility, the company will be able to pioneer advancements and experimentation in formulations, ingredients, and technologies, allowing them to maintain a competitive edge and drive product innovation.

Additionally, the new plant will empower Salve Pharmaceuticals to ensure consistent product quality, personalise offerings, and cater to the needs of emerging companies both in India and internationally.

The new plant will be situated within the Reliance MET Industrial Area, which is located in Jhajjar, Haryana. Developed by Reliance Industries Limited, this expansive industrial hub spans over 8,000 acres and provides world-class infrastructure and facilities to diverse industries.